# A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

> **NCT07276581** · PHASE2 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 320 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AZD1163
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07276581
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2027-11-12
- **Final completion:** 2028-08-18
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276581, "A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07276581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*